Emerging epidemic of metallo-β-lactamase-mediated resistances

Diagnostic Microbiology and Infectious Disease

Volumn 51, Issue 2, 2005, Pages 77-84

  Jones, Ronald N ^a,b   Biedenbach, Douglas J ^a   Sader, Helio S ^a   Fritsche, Thomas R ^a   Toleman, Mark A ^b   Walsh, Timothy R ^c  

^a JMI LABORATORIES   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE; CARBAPENEM; CEFTAZIDIME;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ASIA; DIAGNOSTIC TEST; EDITORIAL; EUROPE; GENE MUTATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; SOUTH AND CENTRAL AMERICA;

EID: 13444262078     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2004.07.003     Document Type: Editorial

References (48)

1. IMP Antimicrob. Agents Chemother. 39 1995 1612 1615
2. Y. Arakawa, N. Shibata, K. Shibayama, H. Kurokawa, T. Yagi, H. Fujiwara, and M. Goto Convenient test for screening metallo-β-lactamase-producing Gram-negative bacteria by using thiol compounds J. Clin. Microbiol. 38 2000 40 43
3. K. Bush Metallo-β-lactamases: A class apart Clin. Infect. Dis. 27 1998 S48 S53
4. K. Bush, G.A. Jacoby, and A.A. Medieros A functional classification scheme for β-lactamases and its correlation with molecular structure Antimicrob. Agents Chemother. 39 1995 1211 1233
5. M. Castanheira, R.E. Mendes, F. Schmitz, M. Toleman, R.N. Jones, and T.R. Walsh Molecular and Biochemical Characterization of a Novel Class B β-Lactamase GIM-1: A New Subclass of Metallo-β-Lactamase: Report From the SENTRY Antimicrobial Surveillance Program Abstract C1-669 Programs and Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, 2003 2003 American Society for Microbiology Washington, DC 76
6. VIM-2 from Latin American medical centres: Report from the SENTRY Antimicrobial Surveillance Program Abstract C2-2023 Programs and Abstract of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, 2003 2003 American Society for Microbiology Washington, DC 153
7. K. Coleman, D.R.J. Griffin, J.W.J. Page, and P.A. Upshon In vitro evaluation of BRLA2715, as novel β-lactamase inhibitor Antimicrob. Agents Chemother. 33 1989 1580 1587
8. A.C. Gales, R.N. Jones, J. Turnidge, R. Rennie, and R. Ramphal Characterization of Pseudomonas aeruginosa isolates: Occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999 Clin. Infect. Dis. 32 2001 S146 S155
9. A.C. Gales, L.C. Menezes, S. Silbert, and H.S. Sader Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-β-lactamase J. Antimicrob. Chemother. 52 2003 699 702
10. A.C. Gales, A.O. Reis, A.P. Penteado, S. Silbert, M.C.B. Tognim, and H.S. Sader IMPs, VIMs and SPMs: The great diversity of metallo-β-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa in a Brazilian hospital Abstract C2-2018 Programs and Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, September 14-17, 2003 2003
11. A.C. Gales, M.C. Tognim, A.O. Reis, R.N. Jones, and H.S. Sader Emergence of an IMP-like metallo-enzyme in an Acinetobacter baumannii clinical strain from a Brazilian teaching hospital Diagn. Microbiol. Infect. Dis. 45 2003 77 79
12. IMP-7 Antimicrob. Agents Chemother. 46 2002 255 258
13. C.G. Giske, M. Rylander, and G. Kronvall VIM-4 in a carbapenem-resistant strain of Pseudomonas aeruginosa isolated in Sweden Antimicrob. Agents Chemother. 47 2003 3034 3035
14. R.M. Hall Antibiotic resistance in Gram-negative bacteria: The role of gene cassettes and integrons Drug Resistance Updates 1 1998 109 119
15. Japan Antimicrobial Resistance Study Group K. Yamaguchi, D. Mathai, D.J. Biedenbach, M.T. Lewis, A.C. Gales, and R.N. Jones Evaluation of the in vitro activity of six broad-spectrum β-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan Diagn. Microbiol. Infect. Dis. 34 1999 123 134
16. Japan Antimicrobial Resistance Study Group M.D. Lewis, K. Yamaguchi, D.J. Biedenbach, and R.N. Jones In vitro evaluation of cefepime and other broad-spectrum β-lactams in 22 medical centers in Japan: A Phase II trial comparing two annual organism samples Diagn. Microbiol. Infect. Dis. 35 1999 307 315
17. R.N. Jones, L.M. Deshpande, J.M. Bell, J.D. Turnidge, S. Kohno, Y. Ono, M. Inoue, and M.A. Toleman Evaluation of the contemporary occurrence rates of metallo-β-lactamases in multi-drug-resistant Gram-negative bacilli in Japan: Report from the SENTRY Antimicrobial Surveillance Program (1998-2002) Diagn. Microbiol. Infect. Dis. 49 2004 289 294
18. C. Lagatolla, E.A. Tonin, C. Monti-Bragadin, L. Dolzani, F. Gombac, C. Bearzi, E. Edalucci, F. Gionechetti, and G.M. Rossolini Endemic carbapenem-resistant Pseudomonas aeruginosa with acquired metallo-β- lactamase determinants in European hospital Emerging Infect. Dis. 10 2004 535 538
19. VIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate Antimicrob. Agents Chemother. 46 1999 289 294
20. K. Lee, Y. Chong, H.B. Shin, Y.A. Kim, D. Yong, and J.H. Yum Modified Hodge and EDTA-disk synergy tests to screen metallo-β-lactamase-producing strains of Pseudomonas and Acinetobacter species Clin. Microbiol. Infect. 7 2001 88 91
21. D.M. Livermore, and N. Woodford Carbapenemases: A problem in waiting? Curr. Opin. Microbiol. 3 2002 489 495
22. F. Luzzaro, J.-D. Docquier, C. Colinon, A. Endimiani, G. Lombardi, G. Amicosante, G.M. Rossolini, and A. Toniolo Emergence in Klebsiella pneumoniae and Enterobacter cloacae clinical isolates of the VIM-4 metallo-β-lactamase encoded by a conjugative plasmid Antimicrob. Agents Chemother. 48 2004 648 650
23. VIM-2 in Latin America: Report from the SENTRY Antimicrobial Surveillance Program Antimicrob. Agents Chemother. 48 2004 1433 1434
24. IMP-16 and a fused form of aminoglycoside resistant gene, aac(6)-30/aac(6′)-lb′: Report from the SENTRY Antimicrobial Surveillance Program Antimicrob. Agents Chemother. 2004 Submitted for publication
25. V. Miriagou, E. Tzelepi, D. Gianneli, and L.S. Tzouvelekis Escherichia coli with a self-transferable, multiresistant plasmid coding for metallo-β-lactamase VIM-1 Antimicrob. Agents Chemother. 47 2003 395 397
26. National Committee for Clinical Laboratory Standards (NCCLS) Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. Approved standard Document M7-A6 6th ed. 2003 NCCLS Wayne, PA
27. National Committee for Clinical Laboratory Standards (NCCLS) Performance standards for antimicrobial susceptibility testing, 14th Informational supplement Document M100-S14 2004 NCCLS Wayne, PA
28. P. Nordmann, and L. Poirel Emerging carbapenemases in Gram-negative aerobes Clin. Microbiol. Infect. Dis. 8 2002 321 331
29. E. Osano, Y. Arakawa, R. Wacharotayankun, M. Ohta, T. Horri, H. Ito, F. Yoshimura, and N. Y Kato Molecular characterization of an enterobacterial metallo-β-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance Antimicrob. Agents Chemother. 38 1994 71 78
30. VIM-4 gene cassette isolated from hospitalized children in Poland (1998-2001) J. Antimicrob. Chemother. 53 2004 451 456
31. M.A. Pfaller, J. Acar, R.N. Jones, J. Verhoef, J. Turnidge, and H.S. Sader Integration of molecular characterization of microorganisms in a global antimicrobial resistance surveillance program Clin. Infect. Dis. 32 2001 S156 S167
32. M.A. Pfaller, C. Wendt, R.J. Hollis, R.P. Wenzel, S.J. Fritschel, J.J. Neubauer, and L.A. Herwaldt Comparative evaluation of an automated ribotyping system versus pulsed-field gel electrophoresis for epidemiological typing of clinical isolates of Escherichia coli and Pseudomonas aeruginosa from patients with recurrent Gram-negative bacteremia Diagn. Microbiol. Infect. Dis. 25 1996 1 8
33. B.A. Rasmussen, and K. Bush Carbapenem-hydrolyzing β-lactamases Antimicrob. Agents Chemother. 41 1997 223 232
34. S. Sardelic, L. Pallecchi, V. Punda-Polic, and G.M. Rossolini Carbapenem-resistant Pseudomonas aeruginosa-carrying VIM-2 metallo-β- lactamase determinants, Croatia Emerging Infect. Dis. 9 2003 1022 1023
35. IMP) in Gram-negative rods resistant to broad-spectrum β-lactams J. Clin. Microbiol. 34 1996 2909 2913
36. K. Senda, Y. Arakawa, K. Nakashima, H.S. Ito, S. Ichiyama, K. Shimokata, N. Kato, and M. Ohta Multifocal outbreaks of metallo-β-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum β-lactams, including carbapenems Antimicrob. Agents Chemother. 49 1996 837 840
37. N. Shibata, Y. Doi, K. Yamane, T. Yagi, H. Kurokowa, K. Shibayama, H. Kato, K. Kai, and Y. Arakawa PCR types of genetic determinants for metallo-β-lactamases and integrases carried by Gram-negative bacteria isolated in Japan, with focus on the Class 3 integron J. Clin. Microbiol. 41 2003 5407 5413
38. T.R. Shyrock The future of anti-infective products in animal health Nat. Rev. 2 2004 425 429
39. B. Spellberg, J.H. Powers, E.P. Brass, L.G. Miller, and J.E. Edwards Jr. Trends in antimicrobial drug development: Implications for the future Clin. Infect. Dis. 38 2004 1279 1286
40. IMP-13, harboured by a novel Tn5051-type transposon disseminating carbapenemase genes in Europe: Report from the SENTRY Worldwide Antimicrobial Surveillance Programme J. Antimicrob. Chemother. 52 2003 583 590
41. VIM-7 from Pseudomonas aeruginosa isolated in the United States: An evolutionary distinct metallo-β-lactamase gene Antimicrob. Agents Chemother. 48 2004 329 332
42. M.A. Toleman, A.M. Simm, T.A. Murphy, A.C. Gales, D.J. Biedenbach, R.N. Jones, and T.R. Walsh Molecular characterization of SPM-1, a novel metallo-β-lactamase isolated in Latin America: Report from the SENTRY Antimicrobial Surveillance Program J. Antimicrob. Chemother. 50 2002 673 679
43. A. Tsakris, P.T. Tassios, F. Polydorou, A. Pap, E. Malaka, A. Antoniadis, and N.J. Legakis Infrequent detection of acquired metallo-β-lactamases among carbapenem-resistant Pseudomonas isolates in a Greek hospital Clin. Microbial. Infect. 9 2003 846 851
44. T.R. Walsh, A. Bolmstrom, A. Qwarnstrom, and A. Gales Evaluation of a new Etest for detecting metallo-β-lactamases in routine clinical testing J. Clin. Microbiol. 40 2002 2755 2759
45. VIM-2 in Eastern Europe: Report from the SENTRY Antimicrobial Surveillance Program J. Antimicrob. Chemother. 52 2003 116 119
46. M. Watanabe, S. Iyobe, M. Inone, and S. Mitsuhashi Transferable imipenem resistance in Pseudomonas aeruginosa Antimicrob. Agents Chemother. 35 1991 147 151
47. D. Yong, K. Lee, J.H. Yum, H.B. Shin, G.M. Rossolini, and Y. Chong Imipenem-EDTA disk method for differentiation of metallo-β-lactamase- producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 40 2002 3798 3801
48. VIM-2 gene cassettes J. Antimicrob. Chemother. 49 2002 837 840